Evidence profile
5-Amino-1MQ
5-Amino-1MQ study rows link each listed finding to its source, model or population, and endpoint.
Cited headline finding
The study reported increased NAD+ and SAM in adipocytes and reduced adiposity in diet-induced-obese mice. ↗
Differentiated adipocytes and diet-induced-obese miceNeelakantan et al., Biochemical Pharmacology 2018Animal
Mechanism scope
How cited research characterizes 5-Amino-1MQ
The cited 5-Amino-1MQ study reports NAD+ and SAM measurements in differentiated adipocytes and adiposity findings in diet-induced-obese mice.
Sources: Neelakantan et al., Biochemical Pharmacology 2018 ↗
Open question
What the cited 5-Amino-1MQ sources do not resolve
The cited 5-Amino-1MQ study does not establish findings beyond its adipocyte and mouse models.
Sources: Neelakantan et al., Biochemical Pharmacology 2018 ↗
| Finding | Year | n | Model or population | Endpoint | Source | Evidence tier |
|---|---|---|---|---|---|---|
| The study reported increased NAD+ and SAM in adipocytes and reduced adiposity in diet-induced-obese mice. | 2018 | Not stated | Differentiated adipocytes and diet-induced-obese mice | Intracellular NAD+/SAM, adipocyte lipogenesis, and mouse adiposity | Neelakantan et al., Biochemical Pharmacology 2018 ↗ | Animal |
Regulatory status
5-Amino-1MQ appears in an FDA warning letter concerning section 503B exemptions for drug products compounded by GenoGenix LLC. ↗
Reviewer: Ember Peptides source-verification editorial review · Review date: 2026-09-13